CMS is approving this time-limited state plan amendment (SPA) to respond to the COVID-19 national emergency. The purpose of this amendment is to allow for an add on hospital payment for Remdesivir. In addition, this SPA provides authority to address the National Emergency by allowing for a temporary premium payment to be paid to specified providers for in-person care, modifying additional payments for specific COVID-19 nursing facilities, and increasing payment for the administration of Emergency Use Authority for investigational drugs, devices, and biological agents to 100% of the Medicare rate.
State
Topics
Approval Date
Effective Date
File 1 - Approval Document Media